![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shintaro Hirata, Nadine Defranoux, Kentaro Hanami, Kunihiro Yamaoka & Yoshiya Tanaka. (2015) A multi-biomarker disease activity score for monitoring rheumatoid arthritis. Current Biomarker Findings 5, pages 69-78.
Read now
Read now
Hanna L Gul, Joana F Ferreira & Paul Emery. (2015) Remission in rheumatoid arthritis: is it all the same?. Expert Review of Clinical Pharmacology 8:5, pages 575-586.
Read now
Read now
Articles from other publishers (16)
Hanna Gul, Kate Harnden & Benazir Saleem. (2021) Defining the Optimal Strategies for Achieving Drug-Free Remission in Rheumatoid Arthritis: A Narrative Review. Healthcare 9:12, pages 1726.
Crossref
Crossref
Carlos Melus, Brenden Rossin, Mary Ann Aure & Michael Mahler. 2021. Precision Medicine and Artificial Intelligence. Precision Medicine and Artificial Intelligence
65
96
.
Martin Jan Bergman. (2020) Treat to Target, Remission and Low Disease Activity in the Treatment of Rheumatoid Arthritis. Current Treatment Options in Rheumatology 6:3, pages 260-267.
Crossref
Crossref
Tate M. Johnson, Kyle A. Register, Cynthia M. Schmidt, James R. O'Dell, Ted R. Mikuls, Kaleb Michaud & Bryant R. England. (2019) Correlation of the Multi‐Biomarker Disease Activity Score With Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta‐Analysis. Arthritis Care & Research 71:11, pages 1459-1472.
Crossref
Crossref
Melanie Hagen, Matthias Englbrecht, Judith Haschka, Michaela Reiser, Arnd Kleyer, Axel Hueber, Bernhard Manger, Camille Figueiredo, Jayme Fogagnolo Cobra, Hans-Peter Tony, Stephanie Finzel, Stefan Kleinert, Jörg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Hans-Martin Lorenz, Hubert Nüsslein, Rieke Alten, Jörg Henes, Klaus Krüger, Georg Schett & Jürgen Rech. (2019) Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status. The Journal of Rheumatology 46:5, pages 460-466.
Crossref
Crossref
Jeffrey R. Curtis, Fenglong Xie, Shuo Yang, Maria I. Danila, Justin K. Owensby & Lang Chen. (2019) Uptake and Clinical Utility of Multibiomarker Disease Activity Testing in the United States. The Journal of Rheumatology 46:3, pages 237-244.
Crossref
Crossref
Rachel Archer, Emma Hock, Jean Hamilton, John Stevens, Munira Essat, Edith Poku, Mark Clowes, Abdullah Pandor & Matt Stevenson. (2018) Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews. Health Technology Assessment 22:66, pages 1-294.
Crossref
Crossref
Gary M Oderda, Grant D Lawless, Grace C Wright, Samuel R Nussbaum, Renwyck Elder, Kibum Kim & Diana I Brixner. (2018) The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs. Personalized Medicine 15:4, pages 291-301.
Crossref
Crossref
Manathip Osiri, Jongkonnee Wongpiyabovorn, Youwanuch Sattayasomboon & Niramol Thammacharoenrach. (2016) Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics. Clinical Rheumatology 35:7, pages 1673-1681.
Crossref
Crossref
Kaleb Michaud, Vibeke Strand, Nancy A. Shadick, Irina Degtiar, Kerri Ford, Steven N. Michalopoulos & John Hornberger. (2015) Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis. Rheumatology 54:9, pages 1640-1649.
Crossref
Crossref
Yara Dadalti Fragoso. (2015) Why some of us do not like the expression “no evidence of disease activity” (NEDA) in multiple sclerosis. Multiple Sclerosis and Related Disorders 4:4, pages 383-384.
Crossref
Crossref
Morten A. Karsdal, Anne-Christine Bay-Jensen, Kim Henriksen, Claus Christiansen, Harry K. Genant, Chris Chamberlain & Adam Platt. (2014) Rheumatoid Arthritis: A Case for Personalized Health Care?. Arthritis Care & Research 66:9, pages 1273-1280.
Crossref
Crossref
Kabita Nanda & Carol Ann Wallace. (2014) The future of treatment for juvenile idiopathic arthritis. International Journal of Clinical Rheumatology 9:2, pages 135-146.
Crossref
Crossref
Kenzie D. MacIsaac, I-Ming Wang, Joseph Menetski & Christopher Roberts. (2014) Genomic and systems approaches to translational biomarker discovery in immunological diseases. Drug Discovery Today 19:2, pages 133-139.
Crossref
Crossref
M.A. Karsdal, C. Christiansen, C. Ladel, K. Henriksen, V.B. Kraus & A.C. Bay-Jensen. (2014) Osteoarthritis – a case for personalized health care?. Osteoarthritis and Cartilage 22:1, pages 7-16.
Crossref
Crossref
Yusuf Yazici & Hilal Maradit Kremers. 2014. Understanding Evidence-Based Rheumatology. Understanding Evidence-Based Rheumatology
127
140
.